Clinical Trials Directory

Trials / Completed

CompletedNCT02945735

Gaze Contingent Feedback in Major Depressive Disorder (MDD)

Gaze Contingent Feedback in Major Depressive Disorder

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Tel Aviv University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether giving gaze-contingent feedback is an effective attention modification procedure, helping in the treatment of Major Depressive Disorder (MDD)

Detailed description

The study examines giving depressive participants gaze-contingent feedback as a novel attention training procedure. Half of the participants will receive contingent feedback while the other half would receive non-contingent "placebo" feedback.

Conditions

Interventions

TypeNameDescription
BEHAVIORALAttention ModificationFeedback according to participants' viewing patterns, in order to modify their attention.

Timeline

Start date
2016-11-06
Primary completion
2019-01-07
Completion
2019-01-07
First posted
2016-10-26
Last updated
2019-12-18

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02945735. Inclusion in this directory is not an endorsement.